VR Adviser’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

VR Adviser’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,866,000	Closed	-$15.9M	–	35
2023 Q1	$15.9M	Hold	1,866,000	–	–	3.1%	14
2022 Q4	$16.2M	Buy	+1,866,000	New	+$15M	2.72%	16

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser's VECT Position: Q2 2023 in Review

VR Adviser sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 1,866,000 shares — an estimated $15.9M sold.

VR Adviser first reported a position in VECT in Q4 2022 and held it in 2 quarters. The position peaked at $16.2M in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

VR Adviser reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
VR Adviser sold 1,866,000 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $15.9M.
VR Adviser first reported a position in VectivBio Holding AG Ordinary Shares in Q4 2022 and held it in 2 quarters.
VR Adviser's VectivBio Holding AG Ordinary Shares position peaked at $16.2M in Q4 2022.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on VR Adviser's 13F filing for Q2 2023, filed 11 Aug 2023.